Pretreatment of patients with atrial fibrillation who undergo electrical cardioversion.
نویسندگان
چکیده
Who Undergo Electrical Cardioversion To the Editor: We read with interest the study by Madrid et al1 in a recent issue of Circulation. They investigated the role of pretreatment with amiodarone alone or combined with irbesartan in patients with long-lasting persistent atrial fibrillation, and concluded that adding irbesartan to amiodarone reduces recurrences. Nonetheless, some points should be stressed. They reported no significant difference in the baseline concomitant medication between the two groups. However, the percentage of both -blockers, and calcium-channel blockers, is higher in the irbesartan group (15% versus 7%, P 0.09, and 9% versus 5%, P 0.3, respectively). Because both decrease intracellular calcium, we believe that both medications should be considered together. When Tieleman et al2 first demonstrated the role of calciumlowering drugs in reducing recurrences of atrial fibrillation after electrical cardioversion, the proportion of patients taking calcium antagonists or -blockers before cardioversion was of borderline significance (P 0.06 and P 0.08, respectively). When considering the overall intracellular calcium-lowering drugs, the proportion became significant (P 0.04). Arranging the Madrid et al data in a similar way, the percentage of calcium-lowering drugs might become statistically significantly lower in the amiodarone group. This could explain part of the lower recurrence rate of atrial fibrillation in the irbesartan group. Moreover, the findings that most of the benefit of irbesartan occurred during the first 2 months after cardioversion supports our hypothesis that the higher prevalence of calcium lowering drugs in the irbesartan group plays a role in the benefit of irbesartan. As we and other groups have demonstrated, calcium-lowering drugs significantly decrease the early recurrence of atrial fibrillation,2,3 whereas an angiotensin I type 1 receptor blocker is expected to improve the structural remodeling during a period of months.4
منابع مشابه
Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
This article reviews the safety and efficacy of ibutilide for use in patients with atrial fibrillation and flutter. Ibutilide, a class III antiarrhythmic agent, is primarily used for conversion of atrial flutter and fibrillation and is a good alternative to electrical cardioversion. Ibutilide has a conversion rate of up to 75% to 80% in recent-onset atrial fibrillation and flutter; the conversi...
متن کاملBefore predicting survival in children with pulmonary hypertension and congenital heart disease...
drug therapy, but not so after adjustment for left ventricular ejection fraction, left atrial diameter or duration of atrial fibrillation. We feel that our results justify the conclusion that “patients who undergo electrical cardioversion display a greater degree and longer duration of mechanical atrial dysfunction than those who convert pharmacologically or spontaneously” (1). We agree with Fa...
متن کاملClinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation.
OBJECTIVES We sought to evaluate the effect of clinical factors on recovery of atrial function after cardioversion for atrial fibrillation. BACKGROUND Lack of effective mechanical atrial function (EMAF) after cardioversion of atrial fibrillation predisposes to thromboembolic complications and delays improvement in functional capacity. METHODS Fifty-two patients underwent cardioversion (grou...
متن کاملبررسی شیوع لخته دهلیز و گوشک دهلیز چپ در بیماران مراجعه کننده با فلوتر دهلیزی بر حسب بیماری زمینهای
Introduction: Most current evidence suggests the risk of left atrial and or auricular thrombi(LA &LAA) in patients with atrial flutter rhythm is similar to patients with atrial fibrillation, but there is still uncertainty in the risk level and the patient's need to receive anticoagulant therapy. Different studies report various frequencies for atrial thrombi and left atrial spontaneous echo-con...
متن کامل[Therapeutic success of a prospective cardioversion protocol for persistent atrial fibrillation].
INTRODUCTION AND OBJECTIVES The best therapeutic approach for persistent atrial fibrillation has yet to be defined. Our aim was to investigate the effects of cardioversion in unselected patients with persistent atrial fibrillation who were treated according to a strict protocol involving pretreatment, cardioversion, and follow-up. METHODS Consecutive patients with persistent atrial fibrillati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation
دوره 107 11 شماره
صفحات -
تاریخ انتشار 2003